• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Foundation Medicine, Inc. (FMI)

    47.76 Down 0.58(1.20%) Feb 27, 4:00PM EST
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    Market Cap:1.35BN/A966.45M2.42B273.48M
    Qtrly Rev Growth (yoy):0.93N/A0.00-0.100.21
    Revenue (ttm): 61.08MN/A275.71M724.92M96.64M
    Gross Margin (ttm):0.55N/A0.620.820.48
    EBITDA (ttm):-45.12MN/A-16.70M204.42M-749.15K
    Operating Margin (ttm): -0.87N/A-0.090.25-0.09
    Net Income (ttm):-52.22MN/A-24.59M110.41MN/A
    EPS (ttm):-1.87N/A-0.781.45N/A
    P/E (ttm):N/AN/AN/A23.5526.90
    PEG (5 yr expected):N/AN/A2.571.661.61
    P/S (ttm):22.29N/A3.583.434.13
    Pvt1 = Clarient, Inc. (privately held)
    GHDX = Genomic Health Inc.
    MYGN = Myriad Genetics Inc.
    Industry = Medical Laboratories & Research

    News on Direct Competitors 

    Currency in USD.